Increases of kinin B1 and B2 receptors binding sites after brain infusion of amyloid-beta 1-40 peptide in rats

Neurobiology of Aging

Volumn 29, Issue 12, 2008, Pages 1805-1814

  Viel, Tania Araujo ^a   Lima Caetano, Ariadiny ^a   Nasello, Antonia Gladys ^a   Lancelotti, Carmen Lucia ^a   Nunes, Viviane Abreu ^b   Araujo, Mariana Silva ^b   Buck, Hudson Sousa ^a  

^a FACULDADE DE CIÊNCIAS MÉDICAS DA SANTA CASA DE SÃO PAULO   (Brazil)

^b FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Amyloid infusion; B1 and B2 receptors; Bradykinin; Cognitive function; Neurodegeneration; Neuroinflammation

Indexed keywords

AMYLOID BETA PROTEIN[1-40]; BRADYKININ RECEPTOR; KININ B1 RECEPTOR; KININ B2 RECEPTOR; UNCLASSIFIED DRUG; AMYLOID BETA PROTEIN; BRADYKININ B1 RECEPTOR; BRADYKININ B2 RECEPTOR; PEPTIDE FRAGMENT;

ALZHEIMER DISEASE; ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; AUTORADIOGRAPHY; BINDING SITE; BRAIN VENTRICLE; CAPSULA INTERNA; CONTROLLED STUDY; HABENULA; HIPPOCAMPAL FIMBRIA; HISTOLOGY; MALE; MEMORY CONSOLIDATION; MEYNERT BASAL NUCLEUS; NERVE DEGENERATION; NEUROANATOMY; NONHUMAN; OPTIC TRACT; PRIORITY JOURNAL; PROTEIN LOCALIZATION; RAT; RECEPTOR BINDING; ANIMAL; BRAIN; DRUG EFFECT; INFUSION; METABOLISM; PROTEIN BINDING; TISSUE DISTRIBUTION; WISTAR RAT;

AMYLOID BETA-PROTEIN; ANIMALS; BINDING SITES; BRAIN; INFUSIONS, PARENTERAL; MALE; PEPTIDE FRAGMENTS; PROTEIN BINDING; RATS; RATS, WISTAR; RECEPTOR, BRADYKININ B1; RECEPTOR, BRADYKININ B2; TISSUE DISTRIBUTION;

EID: 53849099668     PISSN: 01974580     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neurobiolaging.2007.04.019     Document Type: Article

References (54)

1. Akiyama H., Barger S., Barnum S., Bradt B., Bauer J., Cole G.M., Cooper N.R., Eikelenboom P., Emmerling M., Fiebich B.L., Finch C.E., Frautschy S., Griffin W.S., Hampel H., Hull M., Landreth G., Lue L., Mrak R., Mackenzie I.R., McGeer P.L., O'Banion M.K., Pachter J., Pasinetti G., Plata-Salaman C., Rogers J., Rydel R., Shen Y., Streit W., Strohmeyer R., Tooyoma I., Van Muiswinkel F.L., Veerhuis R., Walker D., Webster S., Wegrzyniak B., Wenk G., and Wyss-Coray T. Inflammation and Alzheimer's disease. Neurobiol. Aging 21 3 (2000) 383-421
2. Alakuijala A., Palgi M., Wegelius K., Schmidt M., Enz R., Paulin L., Saarma M., and Pasternack M. GABA receptor rho subunit expression in the developing rat brain. Brain Res. Dev. Brain Res. 154 1 (2005) 15-23
3. Armstrong D.M., Saper C.B., Levey A.I., Wainer B.H., and Terry R.D. Distribution of cholinergic neurons in rat brain: demonstrated by the immunocytochemical localization of choline acetyltransferase. J. Comp. Neurol. 216 1 (1983) 53-68
4. Bergamaschini L., Parnetti L., Pareyson D., Canziani S., Cugno M., and Agostoni A. Activation of the contact system in cerebrospinal fluid of patients with Alzheimer disease. Alzheimer Dis. Assoc. Disord. 12 2 (1998) 102-108
5. Biella G.R., Gnatkovsky V., Takashima I., Kajiwara R., Iijima T., and de Curtis M. Olfactory input to the parahippocampal region of the isolated guinea pig brain reveals weak entorhinal-to-perirhinal interactions. Eur. J. Neurosci. 18 1 (2003) 95-101
6. Buck H.S., Ongali B., Thibault G., Lindsey C.J., and Couture R. Autoradiographic detection of kinin receptors in the human medulla of control, hypertensive, and diabetic donors. Can. J. Physiol. Pharmacol. 80 4 (2002) 249-257
7. Campos M.M., Ongali B., De Souza Buck H., Schanstra J.P., Girolami J.P., Chabot J.G., and Couture R. Expression and distribution of kinin B1 receptor in the rat brain and alterations induced by diabetes in the model of streptozotocin. Synapse 57 1 (2005) 29-37
8. Cassel J.C., Duconseille E., Jeltsch H., and Will B. The fimbria-fornix/cingular bundle pathways: a review of neurochemical and behavioural approaches using lesions and transplantation techniques. Prog. Neurobiol. 51 6 (1997) 663-716
9. Couture R., Harrisson M., Vianna R.M., and Cloutier F. Kinin receptors in pain and inflammation. Eur. J. Pharmacol. 429 1-3 (2001) 161-176
10. Couture R., and Lindsey C.J. Brain kallikrein-kinin system: from receptors to neuronal pathways and physiological functions. In: Quirion R., Björklund, and Hökfelt T. (Eds). Handbook of Chemical Neuroanatomy vol. 16 (2000), Elsevier Science B.V. 241-300 (peptides receptors)
11. Devan B.D., Goad E.H., and Petri H.L. Dissociation of hippocampal and striatal contributions to spatial navigation in the water maze. Neurobiol. Learn. Mem. 66 3 (1996) 305-323
12. Federico P., Borg S.G., Salkauskus A.G., and MacVicar B.A. Mapping patterns of neuronal activity and seizure propagation by imaging intrinsic optical signals in the isolated whole brain of the guinea-pig. Neuroscience 58 3 (1994) 461-480
13. Fibiger H.C. The organization and some projections of cholinergic neurons of the mammalian forebrain. Brain Res. 257 3 (1982) 327-388
14. Frautschy S.A., Horn D.L., Sigel J.J., Harris-White M.E., Mendoza J.J., Yang F., Saido T.C., and Cole G.M. Protease inhibitor coinfusion with amyloid beta-protein results in enhanced deposition and toxicity in rat brain. J. Neurosci. 18 20 (1998) 8311-8321
15. Gozzo A.J., Nunes V.A., Carmona A.K., Nader H.B., von Dietrich C.P., Silveira V.L., Shimamoto K., Ura N., Sampaio U.M., Sampaio C.A.M., and Araujo M.S. Glycosaminoglycans affect the action of human plasma kallikrein on kininogen hydrolysis and inflammation. Int. Immunopharmacol. 2 13-14 (2002) 1861-1865
16. Guo Q., Furukawa K., Sopher B.L., Pham D.G., Xie J., Robinson N., Martin G.M., and Mattson M.P. Alzheimer's PS-1 mutation perturbs calcium homeostasis and sensitizes PC12 cells to death induced by amyloid beta-peptide. Neuroreport 8 1 (1996) 379-383
17. Hake A.M., and Farlow M.R. New concepts in the drug therapy of Alzheimer's disease. Expert Opin. Pharmacother. 2 12 (2001) 1975-1983
18. Hall J.M., and Morton I.K.M. The pharmacology and immunopharmacology of kinin receptors. In: Farmer S.G. (Ed). The Handbook of Immunopharmacology: the Kinin System (1997), Academic Press, London 9-43
19. Hogan D.B., and Patterson C. Treatment of Alzheimer's disease and other dementias-review and comparison of the cholinesterase inhibitors. Can. J. Neurol. Sci. 29 (2002) 306-314
20. Huang H.M., Lin T.A., Sun G.Y., and Gibson G.E. Increased inositol 1,4,5-trisphosphate accumulation correlates with an up-regulation of bradykinin receptors in Alzheimer's disease. J. Neurochem. 64 2 (1995) 761-766
21. Hunter W.M., and Greenwood F.C. Preparation of iodine-131 labeled human growth hormone of high specific activity. Nature 194 (1962) 495-496
22. Iores-Marçal L.M., Viel T.A., Buck H.S., Nunes V.A., Gozzo A.J., Cruz-Silva I., Miranda A., Shimamoto K., Ura N., and Araujo M.S. Brain prolyl oligopeptidase inactivates bradykinin in a model of Alzheimer's disease. Peptides 27 12 (2006) 3363-3369
23. 2+ mobilization is altered in fibroblasts from patients with Alzheimer disease. Proc. Natl. Acad. Sci. U.S.A. 91 2 (1994) 534-538
24. Johnston M.V., McKinney M., and Coyle J.T. Evidence for a cholinergic projection to neocortex from neurons in basal forebrain. Proc. Natl. Acad. Sci. U.S.A. 76 10 (1979) 5392-5396
25. Jong Y.J., Dalemar L.R., Seehra K., and Baenziger N.L. Bradykinin receptor modulation in cellular models of aging and Alzheimer's disease. Int. Immunopharmacol. 2 13-14 (2002) 1833-1840
26. Jong Y.J., Ford S.R., Seehra K., Malave V.B., and Baenziger N.L. Alzheimer's disease skin fibroblasts selectively express a bradykinin signaling pathway mediating tau protein Ser phosphorylation. FASEB J. 17 15 (2003) 2319-2321
27. Joseph K., Shibayama Y., Nakasawa Y., Peerschke E.I.B., Ghebrehiwet B., and Kaplan A.P. Interaction of Factor XII and high molecular weight kininogen with cytokeratin 1 and gC1qr of vascular endothelial cells and with aggregated Aβ protein of Alzheimer's disease. Immunopharmacology 43 (1999) 203-210
28. Kesner R.P., Lee I., and Gilbert P. A behavioral assessment of hippocampal function based on a subregional analysis. Rev. Neurosci. 15 5 (2004) 333-351
29. Kozlowski M.R., Rosser M.P., and Hall E. Identification of 3H-bradykinin binding sites in PC-12 cells and brain. Neuropeptides 12 (1988) 207-211
30. Lindsey C.J., Buck H.S., Fior-Chadi D.R., and Lapa R.C.R.S. Pressor effect mediated by bradykinin in the paratrigeminal nucleus of the rat. J. Physiol. 502 (1997) 119-129
31. Lindsey C.J., Fujita K., and Martins T.O. The central pressor effect of bradykinin in normotensive and hypertensive rats. Hypertension 11 (1988) I126-I129
32. Marceau F., and Bachvarov D.R. Kinin receptors. Clin. Rev. Allergy Immunol. 16 4 (1998) 385-401
33. Marceau F., Hess J.F., and Bachvarov D.R. The B1 receptors for kinins. Pharmacol. Rev. 50 (1998) 357-386
34. 1 receptor: an inducible G protein coupled receptor. Can. J. Physiol. Pharmacol. 75 (1997) 725-730
35. Marceau F., Sabourin T., Houle S., Fortin J.P., Petitclerc E., Molinaro G., and Adam A. Kinin receptors: functional aspects. Int. Immunopharmacol. 2 13-14 (2002) 1729-1739
36. Martins D.T.O., Fior D.R., Nakaie C.R., and Lindsey C.J. Kinin receptors of the central nervous system of spontaneously hypertensive rats related to the pressor response to bradykinin. Br. J. Pharmacol. 103 (1991) 1851-1856
37. McGeer P.L., and McGeer E.G. Inflammation autotoxicity and Alzheimer disease. Neurobiol. Aging 22 6 (2001) 799-809
38. McGeer P.L., and McGeer E.G. The inflammatory response system of brain: implications for therapy of Alzheimer and other neurodegenerative diseases. Brain Res. Brain Res. Rev. 21 2 (1995) 195-218
39. McMahon A., Wong B.S., Iacopino A.M., Ng M.C., Chi S., and German D.C. Calbindin-D28k buffers intracellular calcium and promotes resistance to degeneration in PC12 cells. Brain Res. Mol. Brain Res. 54 1 (1998) 56-63
40. Nitsch R.M., Kim C., and Growdon J.H. Vasopressin and bradykinin regulate secretory processing of the amyloid protein precursor of Alzheimer's disease. Neurochem. Res. 23 5 (1998) 807-814
41. Nitta A., Itoh A., Hasegawa T., and Nabeshima T. Beta-amyloid protein-induced Alzheimer's disease animal model. Neurosci. Lett. 170 1 (1994) 63-66 (erratum in: Neurosci. Lett. 1994; 172 (1-2): 180)
42. Ongali B., Campos M.M., Bregola G., Rodi D., Regoli D., Thibault G., Simonato M., and Couture R. Autoradiographic analysis of rat brain kinin B1 and B2 receptors: normal distribution and alterations induced by epilepsy. J. Comp. Neurol. 461 4 (2003) 506-519
43. Pascale A., Bhagavan S., Nelson T.J., Neve R.L., McPhie D.L., and Etcheberrigaray R. Enhanced BK-induced calcium responsiveness in PC12 cells expressing the C100 fragment of the amyloid precursor protein. Brain Res. Mol. Brain Res. 72 2 (1999) 205-213
44. Paxinos G., and Watson C. The rat brain in stereotaxic coordinates. 4th ed. (1998), Academic Press, San Diego
45. Pepeu G., Giovannelli L., Casamenti F., Scali C., and Bartolini L. Amyloid beta-peptides injection into the cholinergic nuclei: morphological, neurochemical and behavioral effects. Prog. Brain Res. 109 (1996) 273-282
46. 1 receptor expression and function on human brain endothelial cells. J. Neuropat. Exp. Neurol. 59 (2000) 896-906
47. Prat A., Weinrib L., Becher B., Poirier J., Duquette P., Couture R., and Antel J.P. Bradykinin B1 receptor expression and function on T lymphocytes in active multiple sclerosis. Neurology 53 (1999) 2087-2092
48. Raidoo D.M., and Bhoola K.D. Kinin receptors on human neurons. J. Neuroimmunol. 77 (1997) 39-44
49. Raidoo D.M., Ransaroop R., Naidoo S., Müller-Esterl W., and Bhoola K.D. Kinin receptors in human vascular tissue: their role in atheromatous disease. Immunopharmacology 36 (1997) 153-160
50. Tuppo E.E., and Arias H.R. The role of inflammation on Alzheimer's disease. Int. J. Biochem. Cell. Biol. 37 (2005) 289-305
51. Vanzeler M.L., Felicio L.F., and Nasello A.G. Effects of chronic domperidone treatment on rat conditioned avoidance behavior. Braz. J. Med. Biol. Res. 23 9 (1990) 865-868
52. Wotherspoon G., and Winter J. Bradykinin B1 receptor is constitutively expressed in the rat sensory nervous system. Neurosci. Lett. 294 3 (2000) 175-178
53. Zhao H., and Rusak B. Circadian firing-rate rhythms and light responses of rat habenular nucleus neurons in vivo and in vitro. Neuroscience 132 2 (2005) 519-528
54. Zhao W.Q., Ravindranath L., Mohamed A.S., Zohar O., Chen G.H., Lyketsos C.G., Etcheberrigaray R., and Alkon D.L. MAP kinase signaling cascade dysfunction specific to Alzheimer's disease in fibroblast. Neurobiol. Dis. 11 1 (2002) 166-183